Mostrando 2 resultados de: 2
Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis
ArticleAbstract: Background: Hyperprolactinemia is a common side-effect of antipsychotics (APs), which may trigger sePalabras claves:Antipsychotic, first-episode of psychosis, Gene, polymorphism, prolactin, side-effectAutores:Adrián LLerena, Albacete A., Alonso-Solís A., Baeza I., Balanzá-Martínez V., Barcones F., Bergé D., Bernardo M., Bioque M., Bobes J., Boloc D., Bulbena A., Butjosa A., Cabrera B., Castro-Fornieles J., Contreras F., Corripio I., Cuesta M.J., de la Serna E., Del Mar Bonnin C., Díaz-Caneja M.C., Fayed N., García-Portilla M.P., Gassó P., González-Pinto A., Gutiérrez M., Hernandez-Viadel M., Ibáñez Á., Lafuente A., Landín-Romero R., Lobo A., López P., Mané A., Mas S., Morales-Muñoz I., Nacher J., Parellada M., Pina-Camacho L., Pomarol-Clotet E., Rabella M., Rodriguez N., Rodriguez-Jimenez R., Saiz-Ruiz J., Sanjuán J., Sarró S., Solé E., Usall J., Vieta E., Zabala A., Zorrilla I.Fuentes:scopusPharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: Role of dopamine, serotonin and glutamate candidate genes
ArticleAbstract: This study investigated whether the risk of presenting antipsychotic (AP)-induced extrapyramidal symPalabras claves:Autores:Adrián LLerena, Aguilar E.J., Albacete A., Alonso-Solís A., Arbej J., Baeza I., Balanzá-Martínez V., Balbuena A., Barcones F., Bernardo E.G., Bernardo M., Bioque M., Bobes J., Butjosa A., Cabrera B., Contreras F., Corripio I., Cuadrado A.I., Cuesta M.J., de la Serna E., Echevarría R.S., García-Portilla M.P., Gassó P., González-Pinto A., Grasa E., Hernandez M., Lafuente A., Landín-Romero R., Lobo A., Mané A., Martínez-Cengotitabengoa M., Mas S., Meseguer A., Mezquida G., Morales-Muñoz I., Olmeda M.S., Parellada M., Rabadán A.Z., Rodie J.U., Rodriguez-Jimenez R., Saiz-Ruiz J., Sanjuán J., Sarró S., Torrent C., Vieta E.Fuentes:scopus